PharmaVoice Logo

Healthcare Leaders Hub

Can smarter technology selection help de-risk small-molecule development?

Pharma Tech

Can smarter technology selection help de-risk small-molecule development?

Predictive modelling for drug formulation helps developers select promising approaches and identify manufacturing challenges earlier.

Read Full Article
Top 20 Countries in Healthcare Innovation 2026 

PharmaShots

Top 20 Countries in Healthcare Innovation 2026 

Shots  Executive Summary  Healthcare-innovation capacity in 2026 is concentrated in small, research-dense health systems, while the world’s largest market still dominates clinical-research scale. PharmaShots scored 35 high-income and major emerging economies on five public indicators (health spending, physician supply, R&D intensity, researcher density and clinical-trial activity). Sweden (84.4), Austria (82.6), Switzerland (81.0), Denmark (75.8) and… The post Top 20 Countries in Healthcare Innovation 2026  appeared first on PharmaShots.

Read Full Article
OrbiMed raises $3bn to back global life science players 

Pharma Tech

OrbiMed raises $3bn to back global life science players 

The duo of funds will support companies across the biopharma, healthcare technology, diagnostics and medical device disciplines.

Read Full Article
Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities

Express Pharma

Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities

The acquisition enhances Cotecna's ability to support both Indian and international  customers with high-quality and regulatory-compliant testing services  The post Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities appeared first on Express Pharma.

Read Full Article
AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership 

Pharma Tech

AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership 

This insitro deal sees AstraZeneca double down on its plans to enter the MASH market, which is expected to reach a value of $20.3bn in 2032.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Oct 16, 2026, 4:41 PM

Ascendis Pharma’s TransCon CNP (Navepegritide) Receives the CHMP’s Positive Opinion for Achondroplasia in Children

Shots: The CHMP has adopted a positive opinion recommending EU marketing authorization for Ascendis Pharma’s once-weekly TransCon CNP (navepegritide) for achondroplasia in children aged ≥2yrs. whose epiphyses are not closed; the EC decision on the MAA is expected in Q4’26 The opinion followed review of the MAA, incl. clinical data from 3 randomized, double-blind, PBO-controlled… The post Ascendis Pharma’s TransCon CNP (Navepegritide) Receives the CHMP’s Positive Opinion for Achondroplasia in Children appeared first on PharmaShots.

PharmaShots

Oct 16, 2026, 4:38 PM

Sobi and Ionis’ Tryngolza (Olezarsen) Receives the CHMP’s Positive Opinion for Severe Hypertriglyceridemia (sHTG)

Shots: The CHMP has adopted a positive opinion recommending the indication extension of Sobi’s Tryngolza (olezarsen) as an adjunct to diet, in combination with other lipid-lowering therapies, for adults with severe hypertriglyceridemia (sHTG; fasting TG ≥880 mg/dL [≥10 mmol/L]); if confirmed, it would be the first & only RNA-targeted therapy authorised in the EU for… The post Sobi and Ionis’ Tryngolza (Olezarsen) Receives the CHMP’s Positive Opinion for Severe Hypertriglyceridemia (sHTG) appeared first on PharmaShots.

PharmaShots

Oct 16, 2026, 4:36 PM

Johnson & Johnson’s Talvey (Talquetamab) + Daratumumab Receives the CHMP’s Positive Opinion for Relapsed/Refractory Multiple Myeloma

Shots: The CHMP has recommended approval of an indication extension for Johnson & Johnson’s Talvey (talquetamab) + daratumumab ± pomalidomide for adults with relapsed/refractory multiple myeloma (RRMM) who have received ≥1 prior therapy; if approved, it will be the only GPRC5D-targeting bispecific antibody combination for RRMM as early as 2L Recommendation was based on the… The post Johnson & Johnson’s Talvey (Talquetamab) + Daratumumab Receives the CHMP’s Positive Opinion for Relapsed/Refractory Multiple Myeloma appeared first on PharmaShots.

Pharma Tech

Oct 16, 2026, 1:48 PM

Can smarter technology selection help de-risk small-molecule development?

Predictive modelling for drug formulation helps developers select promising approaches and identify manufacturing challenges earlier.

PharmaShots

Oct 16, 2026, 1:30 PM

Top 20 Countries in Healthcare Innovation 2026 

Shots  Executive Summary  Healthcare-innovation capacity in 2026 is concentrated in small, research-dense health systems, while the world’s largest market still dominates clinical-research scale. PharmaShots scored 35 high-income and major emerging economies on five public indicators (health spending, physician supply, R&D intensity, researcher density and clinical-trial activity). Sweden (84.4), Austria (82.6), Switzerland (81.0), Denmark (75.8) and… The post Top 20 Countries in Healthcare Innovation 2026  appeared first on PharmaShots.

PharmaShots

Oct 16, 2026, 12:25 PM

Olympus Launches BF-UCP190F Peripheral EBUS Bronchoscope in the US

Shots: Olympus has launched the BF-UCP190F peripheral endobronchial ultrasound (EBUS) bronchoscope in the US, a slim-diameter scope designed to reach beyond mediastinal lymph nodes to segmental & sub-segmental airways for EBUS-TBNA sampling With a 5.9mm outer diameter at the distal end, 170° upward angulation, a 14° forward oblique view and a shorter distal end vs… The post Olympus Launches BF-UCP190F Peripheral EBUS Bronchoscope in the US appeared first on PharmaShots.

News

Latest industry coverage

Google News

Oct 16, 2026, 8:36 PM

Cephalosporin Drugs Market Forecast to 2035: Demand to Accelerate on Rising Hospital-Acquired Infections - IndexBox

Cephalosporin Drugs Market Forecast to 2035: Demand to Accelerate on Rising Hospital-Acquired Infections  IndexBox

Google News

Oct 16, 2026, 7:52 PM

Up and down the ladder: The latest comings and goings - STAT

Up and down the ladder: The latest comings and goings  STAT

Google News

Oct 16, 2026, 7:30 PM

Nephron Pharmaceuticals Announces Leadership Transition - Business Wire

Nephron Pharmaceuticals Announces Leadership Transition  Business Wire

Google News

Oct 16, 2026, 7:27 PM

Donald Trump raised stakes in drug companies gaining from medicare exemptions, say Democrats - The Economic Times

Donald Trump raised stakes in drug companies gaining from medicare exemptions, say Democrats  The Economic Times

Google News

Oct 16, 2026, 7:12 PM

China Tightens Biotech Export Controls - Briefs Finance

China Tightens Biotech Export Controls  Briefs Finance

Google News

Oct 16, 2026, 7:04 PM

One dead, 5 injured in blast at Bharuch pharma unit - The Times of India

One dead, 5 injured in blast at Bharuch pharma unit  The Times of India

Google News

Oct 16, 2026, 6:55 PM

Verastem Gets a New CEO and $250 Million to Advance Its Cancer Pipeline - Barron's

Verastem Gets a New CEO and $250 Million to Advance Its Cancer Pipeline  Barron's

Google News

Oct 16, 2026, 6:50 PM

Trump's pharma holdings surged as drugmakers benefited from Medicare price negotiation carveouts, Democrats allege - Fierce Pharma

Trump's pharma holdings surged as drugmakers benefited from Medicare price negotiation carveouts, Democrats allege  Fierce Pharma

Google News

Oct 16, 2026, 5:53 PM

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions - Fierce Biotech

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions  Fierce Biotech

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer